Status:
COMPLETED
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease
Lead Sponsor:
University of Massachusetts, Worcester
Conditions:
Graves Disease
Hyperthyroidism
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the surgical management of patient...
Detailed Description
Historically Potassium Iodide was given to patients for 1 week prior to thyroidectomy. This common practice was used to decrease thyroid function and prevent thyroid storm during the thyroidectomy. Ho...
Eligibility Criteria
Inclusion
- Adult patients with a clinical diagnosis of Graves Disease
- Patients who have selected surgical resection as treatment of their Graves Disease
- Prior use of anti thyroid medication so that patient is clinically and biochemically euthyroid
Exclusion
- Patients deemed unfit for surgery by operating surgeon or anesthesist
- Patients who are clinically hyperthyroid or have T3 or T4 levels 2X the upper limit of normal
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00946296
Start Date
April 1 2005
End Date
April 1 2013
Last Update
December 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMASS Memorial Health Care
Worcester, Massachusetts, United States, 01655